:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Bryan Chong, Marniza Saad, Tsung Wen Chong, John Thng, Yu Guang Tan, Kae Jack Tay, Christopher Cheng, Po‐Hung Lin, Jeremy Teoh, Peter Ka‐Fung Chiu, Nathan Lawrentschuk, Renu Eapen, Declan Murphy, Johan Chan, Melvin L.K. Chua, Jeffrey Tuan, John Yuen, Ravindran Kanesvaran, Kenneth Chen
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	BJU International
Online Access:	https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.16632
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of PSMA PET / CT in staging patients with intermediate‐risk prostate cancer
by: Jacinta Bonaddio, et al.
Published: (2025)

Reply to ‘A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer’ by Su et al.
by: Bryan Chong, et al.
Published: (2025)

Indocyanine green in minimally and maximally invasive genitourinary cancer surgery
by: David C. Chen, et al.
Published: (2024)

Emerging radiotracers in prostate cancer: opportunities and challenges
by: Kieran Sandhu, et al.
Published: (2026)

Scribe smarter, not harder: how artificial intelligence scribes stack up against human clinicians
by: Alice Thomson, et al.
Published: (2025)

Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma
by: Muhammad Ali, et al.
Published: (2025)

Can only AI save us from the burden of administration?
by: Nathan Lawrentschuk
Published: (2025)

Cystectomy and lymphadenectomy – we now node how far to go!
by: Jordan Santucci, et al.
Published: (2024)

Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate‐risk prostate cancer
by: Jonathon Carll, et al.
Published: (2025)

Prostate‐specific membrane antigen ( PSMA) ‐ PET ‐avid prostate cancers show stronger PSMA immunohistochemistry staining on biopsy cores
by: Jonathon Carll, et al.
Published: (2026)

A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer
by: Po‐Jung Su, et al.
Published: (2025)

Guideline of guidelines: pelvic lymph node dissection at time of radical prostatectomy
by: Jonathon Carll, et al.
Published: (2026)

Subcutaneous local anaesthetic after transperineal prostate biopsy under general anaesthesia : a randomised trial
by: Abdullah Al‐Khanaty, et al.
Published: (2026)

Lutetium‐177 PSMA – the new snake oil? An Australian experience
by: Kieran Sandhu, et al.
Published: (2025)

Response to Veldi et al.: ‘The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy’ – a critical appraisal
by: Kai Zhang, et al.
Published: (2025)

Focal laser ablation in prostate cancer: a systematic review and meta‐analysis
by: Ymer Bushati, et al.
Published: (2025)

Role of diverting colostomy and reconstruction in managing Fournier's gangrene—a narrative review
by: Siyu Huang, et al.
Published: (2024)

Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis
by: David C. Chen, et al.
Published: (2025)

Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: an operative approach to large renal angiomyolipoma associated with lymphangioleiomyomatosis
by: David C. Chen, et al.
Published: (2024)

Economic analysis of minimally invasive surgical treatments for BPH in the Australian public healthcare system
by: Niranjan Sathianathen, et al.
Published: (2025)

Comment on ‘Stone dust in endourology: a systematic review of its definition, management, and clinical impact’
by: Renu Sah, et al.
Published: (2025)

A meta‐analysis of Retzius‐sparing and hood‐technique robot‐assisted radical prostatectomy
by: Siyu Huang, et al.
Published: (2025)

The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy
by: Kai Zhang, et al.
Published: (2025)

A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer
by: Jianliang Liu, et al.
Published: (2024)

Primary retroperitoneal lymph node dissection in stage II testicular seminoma: a systematic review
by: Jianliang Liu, et al.
Published: (2024)

Focal therapy using a novel cooled laser device for prostate cancer: early trial results
by: Jonathan Kam, et al.
Published: (2026)

Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result
by: Juho Pylväläinen, et al.
Published: (2025)

B ladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate
by: Yu‐Hsiang Lin, et al.
Published: (2024)

Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy
by: David D’Andrea, et al.
Published: (2024)

Outcomes of prostate cancer treatments
Published: (2025)

Response to letter ‘Bladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate’
by: Cristina Cano Garcia, et al.
Published: (2024)

Recent key papers in prostate cancer
Published: (2025)

Perspectives on technology – prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?
by: Christopher Berridge, et al.
Published: (2024)

Aquablation for benign prostatic hyperplasia: real‐world prostate size relevance and bleeding events across 6 years
by: Mario Bitar, et al.
Published: (2025)

Nodal maximum standardised uptake value improves PSMA ‐ PET / CT ‐based nodal staging in intermediate‐ and high‐risk prostate cancer
by: Alexandra S. Bruins Slot, et al.
Published: (2026)

Comment on ‘Aquablation for benign prostatic hyperplasia: real‐world prostate size relevance and bleeding events across 6 years’
by: Shuo Lin, et al.
Published: (2026)

Transperineal prostate biopsy under local vs general anaesthesia: a cost‐effectiveness analysis
by: Matthew J. Roberts, et al.
Published: (2025)

Focal therapy for prostate cancer – when to refer?
by: Nadia Rokan, et al.
Published: (2024)

A novel approach to integrated prostate cancer diagnostics: insights from MRI , prostate biopsy, and pathology reports in a pilot study
by: Erik Thimansson, et al.
Published: (2024)

Screening and active surveillance in prostate cancer: the dilemma continues
by: Freddie C. Hamdy, et al.
Published: (2024)